雾化肾上腺素改善烟雾吸入性急性呼吸窘迫综合征绵羊体外膜氧合期间的氧合
该研究将12只雌性美利奴绵羊制成烟雾吸入损伤模型,当PaO2/FiO2低于150 mmHg时启动VV ECMO,随机分为盐水雾化组(对照组,n=7)和肾上腺素雾化组(治疗组,n=5),每4小时雾化一次,ECMO血流维持60-80 mL/kg/min,监测72小时。治疗组生存率显著更高(P=0.03),且在30和36小时PaO2/FiO2较对照组显著改善(P<0.05),氧合与时间呈正相关(相关系数=0.8,P<0.01);治疗组气管湿干重比更低(P<0.05),提示气道水肿减轻;未观察到显著全身心血管效应。作者认为雾化肾上腺素可能是有前景的辅助治疗,可改善烟雾吸入相关ARDS的结局并缩短ECMO时长。
要点
- 在烟雾吸入性ARDS绵羊VV ECMO模型中,每4小时雾化肾上腺素组生存率显著高于盐水雾化组(P=0.03)。
- 治疗组在30和36小时PaO2/FiO2较对照组显著改善(P<0.05),氧合与时间正相关(相关系数=0.8,P<0.01)。
- 治疗组气管湿干重比较对照组更低(P<0.05),提示气道水肿减轻。
- 研究未观察到雾化肾上腺素引起显著全身心血管效应。
- 作者认为雾化肾上腺素可能作为烟雾吸入相关ARDS的辅助治疗,改善结局并缩短ECMO时长。
适用人群与场景
- 雌性美利奴绵羊烟雾吸入损伤模型,当PaO2/FiO2低于150 mmHg时启动VV ECMO。
诊断标准与关键阈值
- VV ECMO启动标准:PaO2/FiO2低于150 mmHg。
处置流程与药物剂量
- VV ECMO启动后,随机接受盐水雾化(对照组,n=7)或肾上腺素雾化(治疗组,n=5),每4小时一次。
- ECMO血流维持60-80 mL/kg/min,绵羊在ECMO启动后保持清醒并置于笼中。
研究设计与关键结果
- 研究类型:动物实验(绵羊模型),12只雌性美利奴绵羊随机分为盐水雾化组(n=7)和肾上腺素雾化组(n=5),监测72小时。
- 主要生存结果:治疗组生存率显著高于对照组(P=0.03)。
- 氧合结果:治疗组在30和36小时PaO2/FiO2较对照组显著改善(P<0.05),氧合与时间正相关(相关系数=0.8,P<0.01)。
- 气道水肿结果:治疗组气管湿干重比较对照组更低(P<0.05)。
- 安全性结果:未观察到显著全身心血管效应。
证据类型、等级与局限
- 证据类型:动物实验(绵羊模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,雾化肾上腺素可能作为烟雾吸入相关ARDS接受VV ECMO支持时的辅助治疗,以改善氧合、减轻气道水肿并提高生存率。
- 作者认为,雾化肾上腺素可能有助于改善结局并缩短ECMO时长。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Smoke inhalation injury induces airway edema, obstruction, and bronchospasm, leading to hypoxia and acute respiratory distress syndrome (ARDS). When ARDS is refractory to conventional therapy, veno-venous extracorporeal membrane oxygenation (VV ECMO) is used as a rescue strategy. We hypothesized that nebulized epinephrine improves oxygenation by alleviating airway dysfunction during VV ECMO support.
METHODS: Twelve female Merino sheep were surgically instrumented and subjected to smoke inhalation injury. VV ECMO was initiated when the PaO 2 /FiO 2 ratio dropped below 150 mmHg. The sheep were randomized to receive either saline nebulization (control group, n = 7) or epinephrine nebulization (treatment group, n = 5) every 4 hours. Extracorporeal membrane oxygenation (ECMO) blood flow was maintained at 60-80 mL/kg/min; the sheep remained conscious in cages after ECMO initiation. Cardiopulmonary variables, blood gases, and respiratory mechanics were monitored for 72 hours.
RESULTS: Survival was significantly higher in the treatment group ( P = 0.03). The PaO 2 /FiO 2 ratio improved significantly in the treatment group at 30 and 36 hours compared with the control group ( P < 0.05), with a positive correlation between oxygenation and time (correlation coefficient = 0.8, P < 0.01). The tracheal wet-to-dry weight ratio was lower in the treatment group ( P < 0.05), indicating reduced airway edema. No significant systemic cardiovascular effects were observed.
CONCLUSIONS: This study demonstrates that nebulized epinephrine improved oxygenation, reduced airway edema, and enhanced survival in an ovine model of smoke inhalation-induced ARDS supported with VV ECMO. These findings suggest that epinephrine nebulization may provide a promising adjunctive therapy to improve outcomes and facilitate shorter ECMO duration in smoke inhalation-associated ARDS.
参考来源
- Kakizaki R, Nakamoto K, Batsaikhan TA, et al. Nebulized Epinephrine Improves Oxygenation During Extracorporeal Membrane Oxygenation in Sheep with Smoke Inhalation-Induced Acute Respiratory Distress Syndrome. Shock. 2025. PMID: 41165743. doi:10.1097/SHK.0000000000002724
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。